Badri S, Mchachi A, Alnadhari M, Benhmidoune L, Chakib A, Rachid R, Elbelhadji M, Amraoui A
Service d'ophtalmologie, hôpital 20-Août-1953, CHU Ibn-Rochd, Casablanca, Maroc; Faculté de médecine et de pharmacie de Casablanca, université Hassan II, Ain Chock, Maroc.
J Fr Ophtalmol. 2019 Feb;42(2):166-169. doi: 10.1016/j.jfo.2018.06.009. Epub 2019 Jan 22.
Cross-linking (CXL) is a technique whose design aims to achieve a specific goal: to harden the corneal tissue of eyes with a progressive form of keratoconus. Other indications are being investigated, such as treatment of infectious keratitis and prevention of corneal ectasia post corneal ablative refractive surgery. Hardening the cornea means changing its biomechanical properties. The existence of true corneal hardening after CXL would inevitably result in an increase in measured intraocular pressure (IOP). This would have a considerable impact in the screening and follow-up of glaucoma patients who have undergone cross-linking because of the central role of IOP measurement in glaucomatous pathology.
交联（CXL）是一种技术，其设计目的是实现一个特定目标：硬化患有进行性圆锥角膜的眼睛的角膜组织。其他适应症正在研究中，如感染性角膜炎的治疗以及角膜屈光性切削术后角膜扩张的预防。硬化角膜意味着改变其生物力学特性。交联后真正的角膜硬化的存在将不可避免地导致测量的眼压（IOP）升高。这将对因眼压测量在青光眼病理中起核心作用而接受交联的青光眼患者的筛查和随访产生重大影响。
